ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Iovance Biotherapeutics, INC.

Official 2024 U.S. DOL Form 5500 summary for Iovance Biotherapeutics, INC. (Iovance Biotherapeutics, INC. 401(k) Plan · EIN 75-3254381 · PN 001): $61.47M net assets, 832 active participants, and $23.20 per $10,000 (23.20 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorIovance Biotherapeutics, INC.
Filing IdentifierIovance Biotherapeutics, INC. 401(k) Plan · EIN 75-3254381 · PN 001
Plan Category & State401(k) Defined Contribution (CA)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$61.47M
Active Participants832
Direct Admin Fee Rate$23.20 per $10,000 (23.20 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI